市場調査レポート
商品コード
1567075

HIVポイントオブケア(POC)検査市場:パイプラインレポート(開発段階、セグメント、地域・国、規制経路、主要企業)、2024最新版

HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


出版日
発行
GlobalData
ページ情報
英文 112 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
HIVポイントオブケア(POC)検査市場:パイプラインレポート(開発段階、セグメント、地域・国、規制経路、主要企業)、2024最新版
出版日: 2024年09月23日
発行: GlobalData
ページ情報: 英文 112 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

HIVポイントオブケア(POC)検査は、検査室外で実施される迅速検査であり、検査室での確定検査の前に、推定診断として使用されます。ポイントオブケア(POC)検査は、臨床検査室の外で、患者が治療を受けている場所の近くで実施される医療診断検査と定義されます。POC検査は通常、検査室以外の人員によって実施され、その結果は臨床的な意思決定に用いられます。POCには、手動の手法から自動分析装置まで、さまざまな複雑さと手技があります。

当レポートでは、HIVポイントオブケア(POC)検査市場について調査し、製品概要と開発中のパイプライン製品動向、様々な開発段階にある製品の比較分析や進行中の臨床試験に関する情報、参入企業の最近の動向などを提供しています。

目次

第1章 目次

第2章 イントロダクション

  • HIVポイントオブケア(POC)検査の概要

第3章 開発中の製品

  • HIVポイントオブケア(POC)検査 - 開発段階別パイプライン製品
  • HIVポイントオブケア(POC)検査 - 地域別パイプライン製品
  • HIVポイントオブケア(POC)検査 - 規制経路別パイプライン製品
  • HIVポイントオブケア(POC)検査 - 推定承認日別パイプライン製品
  • HIVポイントオブケア(POC)検査 - 進行中の臨床試験

第4章 HIVポイントオブケア(POC)検査- 企業が開発中のパイプライン製品

  • HIVポイントオブケア(POC)検査企業- 開発段階別のパイプライン製品
  • HIVポイントオブケア(POC)検査- 開発段階別のパイプライン製品

第5章 HIVポイントオブケア(POC)検査企業と製品の概要

第6章 HIVポイントオブケア(POC)検査-最近の動向

第7章 付録

図表

List of Tables

  • HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
  • HIV Point of care (POC) Tests - Pipeline Products by Territory
  • HIV Point of care (POC) Tests - Pipeline Products by Regulatory Path
  • HIV Point of care (POC) Tests - Pipeline Products by Estimated Approval Date
  • HIV Point of care (POC) Tests - Ongoing Clinical Trials
  • HIV Point of care (POC) Tests Companies - Pipeline Products by Stage of Development
  • HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
  • Glossary

List of Figures

  • HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
  • HIV Point of care (POC) Tests - Pipeline Products by Territory
  • HIV Point of care (POC) Tests - Pipeline Products by Regulatory Path
  • HIV Point of care (POC) Tests - Pipeline Products by Estimated Approval Date
  • HIV Point of care (POC) Tests - Ongoing Clinical Trials
目次
Product Code: GDME1825EPD

GlobalData's Medical Devices sector report, "HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the HIV Point of care (POC) Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

HIV Point of care (POC) Tests are rapid tests that are carried out outside of the laboratory setting and are used as a presumptive diagnosis prior to confirmatory laboratory testing. Point of Care (POC) Testing is defined as medical diagnostic testing performed outside the clinical laboratory in close proximity to where the patient is receiving care. POC testing is typically performed by non-laboratory personnel and the results are used for clinical decision making. POC has a range of complexity and procedures that vary from manual methodologies to automated analyzers.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the HIV Point of care (POC) Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of HIV Point of care (POC) Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of HIV Point of care (POC) Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 HIV Point of care (POC) Tests Overview

3 Products under Development

  • 3.1 HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
  • 3.2 HIV Point of care (POC) Tests - Pipeline Products by Territory
  • 3.3 HIV Point of care (POC) Tests - Pipeline Products by Regulatory Path
  • 3.4 HIV Point of care (POC) Tests - Pipeline Products by Estimated Approval Date
  • 3.5 HIV Point of care (POC) Tests - Ongoing Clinical Trials

4 HIV Point of care (POC) Tests - Pipeline Products under Development by Companies

  • 4.1 HIV Point of care (POC) Tests Companies - Pipeline Products by Stage of Development
  • 4.2 HIV Point of care (POC) Tests - Pipeline Products by Stage of Development

5 HIV Point of care (POC) Tests Companies and Product Overview

6 HIV Point of care (POC) Tests- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer